Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients
NCT03867916 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2023-01-12
Summary
This phase I/II trial studies how well patient portal and navigation program work in providing information for Asian American cancer patients. Patient portal and navigation program may help to improve the care provided to Asian American cancer patients.This study is offered in the following languages in addition to English: Chinese (Cantonese or Mandarin) and Vietnamese.
Conditions
- Caregiver
- Malignant Neoplasm
- Physician
- Stage I Colorectal Cancer AJCC v8
- Stage I Liver Cancer
- Stage I Lung Cancer AJCC v8
- Stage IA1 Lung Cancer AJCC v8
- Stage IA2 Lung Cancer AJCC v8
- Stage IA3 Lung Cancer AJCC v8
- Stage IB Lung Cancer AJCC v8
- Stage II Colorectal Cancer AJCC v8
- Stage II Liver Cancer
- Stage II Lung Cancer AJCC v8
- Stage IIA Colorectal Cancer AJCC v8
- Stage IIA Lung Cancer AJCC v8
- Stage IIB Colorectal Cancer AJCC v8
- Stage IIB Lung Cancer AJCC v8
- Stage IIC Colorectal Cancer AJCC v8
- Stage III Colorectal Cancer AJCC v8
- Stage III Liver Cancer
- Stage III Lung Cancer AJCC v8
- Stage IIIA Colorectal Cancer AJCC v8
- Stage IIIA Lung Cancer AJCC v8
- Stage IIIB Colorectal Cancer AJCC v8
- Stage IIIB Lung Cancer AJCC v8
- Stage IIIC Colorectal Cancer AJCC v8
- Stage IIIC Lung Cancer AJCC v8
Interventions
- BEHAVIORAL
-
Patient Navigation Program
Use patient navigation program
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
- OTHER
-
Survey Administration
Ancillary studies
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of California, San Francisco
lead OTHER
Principal Investigators
-
Tung T Nguyen, MD · University of California, San Francisco
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-12-13
- Primary Completion
- 2022-11-30
- Completion
- 2022-12-31
Countries
- United States
Study Locations
More Related Trials
-
Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion
NCT02011997 ·Status: UNKNOWN ·Phase: PHASE3
-
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer
NCT03505515 ·Status: COMPLETED
-
Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung Cancer
NCT03673657 ·Status: COMPLETED ·Phase: PHASE2
-
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
NCT06377124 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Cryoablation with Robotic Bronchoscopy System in Patients with Lung Cancer
NCT06832956 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
NCT06019455 ·Status: RECRUITING
-
Factors Influencing Cancer Patients Participation in Clinical Trials in China.
NCT03412344 ·Status: UNKNOWN
-
An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy
NCT00721981 ·Status: TERMINATED
-
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
NCT05532527 ·Status: UNKNOWN ·Phase: NA
-
Study on the Accessibility and Feasibility of Intelligent Applet for Health Intervention of Cancer Patients
NCT05501990 ·Status: RECRUITING ·Phase: NA
-
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
NCT05834413 ·Status: RECRUITING ·Phase: NA
-
A Mobile SMART Exercise Support Program to Improve Fatigue in Lung Cancer Patients - A RCT
NCT05331391 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer
NCT03679936 ·Status: UNKNOWN
-
A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
NCT07119190 ·Status: NOT_YET_RECRUITING
-
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
NCT04465214 ·Status: COMPLETED
-
Precision Diagnosis and Therapy for Early Stage Lung Cancer
NCT02936804 ·Status: UNKNOWN ·Phase: NA
-
Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
NCT00005071 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Contribution of a DEMaterialized VIdeo-pedagogical SUpport in the Care Pathway of Lung Cancer Surgery Patients
NCT06577844 ·Status: RECRUITING ·Phase: NA
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
NCT07291921 ·Status: RECRUITING
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients
NCT06629714 ·Status: COMPLETED
-
Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC
NCT07250360 ·Status: COMPLETED
-
Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer
NCT06572540 ·Status: RECRUITING ·Phase: NA
-
Navigate - Improving Survival and Quality of Life in Vulnerable Lung Cancer Patients
NCT05053997 ·Status: RECRUITING ·Phase: NA